Login
If you do not have an account, you can create one by clicking "My Account" or "APPLY" in the navigation menu.
2025-2026 RESEARCH GRANTS
CALL FOR ABSTRACTS ARE NOW OPEN!
2025-2026 FOUNDATION FOR WOMEN’S CANCER
RESEARCH GRANTS
Further guidelines for submission and the application process can be found here.
Each application will be eligible for all grants that it applies to.
Questions? Visit our FAQ page
Still have questions after reading the FAQs? Reach out to the Foundation for Women’s Cancer research program at research@sgo.org.
FOUNDATION FOR WOMEN’S CANCER RESEARCH GRANTS
GENERAL GYNECOLOGIC CANCERS
Foundation for Women's Cancer
Move4Her Research Grant
This grant is open to all gynecologic cancers.
The Foundation gratefully acknowledges all participants and supporters of this year's Move4Her campaign for making this grant possible.
This is the fifth research grant funded through Move4Her.
$50,000 one-year research grant
Abstracts due by October 27, 2025
Grant in Memory of Peggy A. Yates
This grant is related to all gynecologic cancers except ovarian cancer.
No fetal tissue may be used when conducting this research. The Foundation gratefully acknowledges the family of Peggy A. Yates for support of this grant.
This is the fifth research grant funded by the Yates family.
$50,000 one-year research grant
Abstracts due by October 27, 2025
Winter Meeting SGO Early Career Professional Research Grant
This grant is related to all gynecologic cancers.
The Foundation gratefully acknowledges all SGO members who contributed to this grant during the 2025 SGO Winter Meeting.
This is the second research grant funded through SGO member and meeting attendee donations during the SGO Winter Meeting.
$50,000 one-year research grant
Abstracts due by October 27, 2025
Brief for A Research Grant Focused on Innovative Uses of Personalized Molecular Residual Disease Testing in Gynecologic Cancers
This grant application invites proposals for research projects that incorporate personalized Molecular Residual Disease testing (MRD) to advance the management of gynecologic cancers. Projects should focus on innovative uses of MRD in gynecologic cancers, including but not limited to:
- Prospective interventional or decision-impact studies to evaluate the clinical utility of MRD for optimizing treatment strategies in ovarian, endometrial, cervical, or other gynecologic cancers.
- Treatment monitoring studies utilizing ctDNA dynamics to inform escalation, de-escalation, or switching of therapy.
- Investigations of ctDNA as a surrogate endpoint for treatment efficacy and/or survival in clinical trials.
- Evaluation of the potential of MRD-guided interventions to reduce overtreatment or toxicity, including financial toxicity.
- MRD-guided surveillance studies that utilize ctDNA dynamics to inform imaging and/or treatment escalation.
Priority will be given to prospective, interventional designs that explore the value of MRD-informed care for patients with gynecological cancer. Proposals that focus on MRD feasibility/detectability in gynecologic cancer and/or general prognostic value of MRD in gynecologic cancers will be given less priority.
Investigators with biobank-related project proposals may contact Natera directly by filling out a Natera Sponsored Trials research form. Biobank study criteria are listed below:
- Serial timepoints available, with >5 mL of plasma collected and banked per timepoint.
- Tumor tissue available for assay development and analysis.
- Matched normal whole blood or other sample types that allow for germline analysis.
- Clinical follow-up data available to enable correlation of MRD results with interventions and outcomes.
$50,000 one-year research grant
Abstracts due by October 27, 2025
OVARIAN CANCER
National Ovarian Cancer Coalition
Early Detection Research Grant
Emphasis on Early Detection
The National Ovarian Cancer Coalition (NOCC) supports their mission to save lives through the prevention and cure of ovarian cancer in part by donating to ovarian cancer research. Since their founding in 1991, NOCC has become an important national advocate for patients and families fighting ovarian cancer. This is the NOCC's fifth year supporting the FWC Research Grants program. The Foundation gratefully acknowledges the NOCC for their support of this grant.
$50,000 one-year research grant
Abstracts due by October 27, 2025
National Ovarian Cancer Coalition
Quality of Life Research Grant
This is the National Ovarian Cancer Coalition's (NOCC) fifth year funding research through the FWC. This grant is focused on Quality of Life in relation to ovarian cancer. NOCC is making this funding available as part of their commitment to investing in meaningful research that serves the ovarian cancer community. The Foundation gratefully acknowledges the NOCC for their support of this grant.
$50,000 one-year research grant
Abstracts due by October 27, 2025
National Ovarian Cancer Coalition Health Equity & Diversity Research Grant
The National Ovarian Cancer Coalition is proud to announce their one-year grant to support innovative research focused on addressing health disparities and advancing equity in ovarian cancer prevention, diagnosis, treatment, and survivorship. Priority will be given to projects that explore the impact of social determinants of health, improve access to care, and promote diversity and inclusion in ovarian cancer research.
$50,000 one-year research grant
Abstracts due by October 27, 2025
The St. Louis Ovarian Cancer Awareness
Research Grant for Ovarian Cancer
St. Louis Ovarian Cancer Awareness (SLOCA) is committed to impacting ovarian cancer survivorship by promoting awareness of early warning signs and standards of care, funding ovarian cancer research, & supporting survivors. This is the 20th research grant supported by SLOCA. The Foundation gratefully acknowledges SLOCA for their support of this grant.
$50,000 one-year research grant
Abstracts due by October 27, 2025
Amy Krouse Rosenthal Foundation Research Grant for Early Detection of Ovarian Cancer
The Amy Krouse Rosenthal Foundation Ovarian Cancer Early Detection grant supports research in early detection and recurrence biomarker development.
Research focus:
The funded project must fall under one of the following areas:
- Early detection of premalignant lesions (e.g., serous tubal intraepithelial carcinoma/STIC) using methods such as:
- Serum/plasma analysis
- Uterine lavage
- Pap smears
- Fallopian tube sampling
- Biomarker development for early ovarian cancer recurrence.
- Identification of high-risk patients (e.g., BRCA or PALB2 carriers) and methods for early detection in these populations.
$72,500 one-year research grant
Abstracts due by October 27, 2025
Laura Crandall Brown Foundation Ovarian Cancer Early Detection Grant
The Laura Crandall Brown Ovarian Cancer Foundation graciously offers this grant in memory of Laura Crandall Brown, who passed away at the age of 25 from ovarian cancer. As part of their mission of research, support, and empowering communities, this eighth grant in partnership with FWC focuses on early detection. The Foundation gratefully acknowledges the Laura Crandall Brown Ovarian Cancer Foundation for their support.
$50,000 one-year research grant
Abstracts due by October 27, 2025
CERVICAL CANCER
The Harold and Barbara Rosenbaum Family Foundation Cervical Cancer Diversity in Prevention and Clinical Research Grant
This grant supports research focused on the intersection of diversity and cervical cancer research. Proposals should seek to eliminate inequities in cervical cancer care and increase representation of underrepresented groups in the cervical cancer community. This is the third grant supported by the Harold and Barbara Rosenbaum Family Foundation.
Proposals should seek to eliminate inequities in cervical cancer care, specifically related to differential outcomes experienced by people from underserved or marginalized populations with cervical cancer, and to increase representation of underrepresented groups in the cervical cancer community as a strategy to achieve health equity for underserved people. This is the second grant supported by the Harold and Barbara Rosenbaum Family Foundation. The Foundation gratefully acknowledges the Harold and Barbara Rosenbaum Family Foundation for their support of this grant.
Those eligible to apply are those who propose a study focused on a marginalized group, or those who are from an underrepresented group within the field of research including but not limited to racially and/or ethnically marginalized, rural, and lower socioeconomic status communities.
Information on underrepresented groups as identified by the NIH can be found here. Information on underrepresented populations as a focus of research can be found here.
$50,000 one-year research grant
Abstracts due by October 27, 2025
ENDOMETRIAL/UTERINE CANCER
Wilma Williams Education and Clinical
Research Grant for Endometrial Cancer
This grant honors both Wilma Williams and the tireless work and dedication of all gynecologic oncologists. The Foundation gratefully acknowledges Dr. James Orr & Mrs. Vicki Orr for their support of this grant. This is the twelfth grant supported by Dr. James Orr & Mrs. Vicki Orr.
$25,000 one-year research grant
Abstracts due by October 27, 2025
BRIDGES 2.0 ACCELERATOR
FWC BRIDGES 2.0 Accelerator Research Grants
Two 2025–2026 FWC BRIDGES 2.0 Accelerator Research Grants are made possible by the Foundation for Women's Cancer to amplify the impact of BRIDGES research protocols.
Eligibility: Current or former SGO/GOG-F BRIDGES Scholars developing an interventional clinical trial under the mentorship of BRIDGES faculty mentors.
- Preclinical studies supporting a proposed clinical trial (e.g., agent activity, tissue-based endpoints, toxicity/dose selection).
- Pilot studies to optimize instruments (e.g., survey validation, translated patient materials).
- Outreach to align protocols with community priorities (e.g., advisory boards, patient advocate engagement).
- Integration of correlative studies to confirm on-target effects or identify biomarkers for phase II/III trials.
- Multisite expansion via collaboration with other BRIDGES scholars.
- Real-world data to inform trial design and clinical relevance.
- Other initiatives that accelerate launch or expand trial impact.
Two one-year research grants of up to $50,000 each.
Abstracts due by October 27, 2025
MULTI-TYPE GYNECOLOGIC CANCER GRANTS
The Genmab Research Grant Advancing Innovation in Ovarian and Endometrial Cancer
This grant focuses on understanding FRα expression levels throughout the disease trajectory of ovarian or endometrial cancer. Priority will be given to supporting research that enhances our understanding of folate receptor alpha (FRα) expression levels throughout the progression of ovarian and/or endometrial cancer. These insights could inform treatment decision-making and enable more precise patient stratification, ultimately improving clinical outcomes. Representation of underserved populations will be a highly valued feature in the review of submissions.
$50,000 one-year research grant
Abstracts due by October 27, 2025
Institute for Surgical Excellence — Surgical Innovation Research Grant
This grant supports pioneering projects that will develop a novel community-based screening program with a website and digital app using artificial intelligence (AI) with advanced imaging technologies—such as Magnetic Resonance Imaging (MRI) and/or ultrasound to improve the early identification of gynecologic cancers, specifically uterine and/or ovarian cancer. The goal of this initiative is to foster innovation and collaboration among researchers, clinicians, and technologists to develop novel screening pathways and strategies. By advancing these cutting-edge solutions, the grant seeks to reduce the incidence of gynecologic cancers, enhance early detection, and ultimately improve outcomes for women worldwide.
$50,000 one-year research grant
Abstracts due by October 27, 2025
Wendy R. Brewster MD, PhD Early Career Grant
This grant honors the legacy of SGO Elected 56th President Wendy Brewster, MD, PhD and supports research of early career investigators demonstrating commitment in the field of gynecologic oncology with a focus on cervical or endometrial cancer research. Individuals from small to medium-sized institutions are highly encouraged to apply.
The Foundation gratefully acknowledges Dr. Brewster for her remarkable life and many accomplishments, as well as the generous support of all who have contributed to the FWC Wendy R. Brewster, MD, PhD Endowment. This year the endowment will fund an Early Career Research Grant, continuing Dr. Brewster's commitment to improving women's health.
$25,000 one-year research grant
Abstracts due by October 27, 2025
Share